Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Measles Vaccine at 4 Months to Reduce Child Mortality
NCT01644721Phase 4Completed
- Sponsor
- Bandim Health Project
- Start
- Jul 2012
- Primary completion
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Edmonston-Zagreb measles vaccine in measles (2 arms), sponsored by Bandim Health Project. Primary endpoint: Overall Mortality. Started Jul 2012; status: completed.
02
Drugs
Edmonston-Zagreb measles vaccine
03
Conditions
measles
Beyond the preview
Go deeper on NCT01644721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01644721.